In a May 3, 2025 article published in BioCentury, Capitol Street’s Ipsita Smolinski discussed possible ways MFN policies could be implemented. Additionally, she covers provisions in an April Executive Order on drug pricing, and how the EO may affect CMS, CMMI, and MFN policies.